U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
National Organization Activities for Cancer Control in Underserved Populations
Announcement Type: New – Type 1
Funding Opportunity Number: CDC- FOA DP08-815
Catalog of Federal Domestic Assistance Number: 93.283.
Key Dates:
Letter of Intent Deadline: May 22, 2008
Application Deadline: June 23, 2008
Authority: This program is authorized under sections 317 (k) (2) of the PHS Act, 42 U.S.C Section 247b(k)(2).
Purpose:
This program will assist national organizations to develop, enhance and coordinate cancer prevention and control activities for individuals who may be underserved, uninsured or underinsured, at risk, or of racial/ethnic minorities. As part of this, CDC will work with established national programs in developing, disseminating and coordinating comprehensive cancer prevention, early detection, and/or survivorship activities for these underserved populations to various levels of action throughout the country, whether national, state or local/community.
This program addresses the “Healthy People 2010” focus area of Cancer. Measurable outcomes of the program will be in alignment with the following goal of the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP): to increase early detection, prevention, or survivorship of cancers of the breast, cervix, colon, prostate, skin, and ovary for underserved and priority populations. This includes, but is not limited to African Americans, American Indian/Alaska Natives, Asian Americans, Native Hawaiians, and other Pacific Islanders, Hispanics, older Americans, rural and urban Americans as well as other disparate populations as identified by the applicant. These populations are deemed “priority” in that they are underserved populations.
This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be reviewed. For the definition of research, please see the CDC Web site at the following Internet address: http://www.cdc.gov/od/science/regs/hrpp/researchDefinition.htm
Activities:
Awardee activities for this program are as follows:
SEQ CHAPTER \h \r 1a. Develop and disseminate programs or strategies designed to improve cancer prevention, early detection, and/or survivorship among the priority population including strategies to improve knowledge, attitudes, and behaviors regarding cancer prevention, early detection, and/or survivorship. Performance will be measured by the extent to which high quality data was used to guide project development and implementation; the extent to which the program develops a mechanism for reaching its constituency with intervention information and/or activities to reach the priority population; whether methods identified to ultimately reach the priority population either directly or through their constituency were appropriate; and the extent to which measurable outcomes are meaningful and numerous enough to suggest adequate programmatic reach.
b. Establish relationships with Comprehensive Cancer Control Coalitions or partners, CDC-funded state health departments, and, as appropriate, American Indian/Alaska Native organizations, U.S. territories, the District of Columbia, and/or other organizations implementing cancer education and awareness activities or programs regarding cancer prevention, early detection or survivorship in these populations. Performance will be measured based on the extent the program coordinates with appropriate coalitions and partnerships in developing and implementing proposed activities.
c. Participate in the dissemination and sharing of pertinent program information with other CDC-funded grantees and appropriate agencies and partners for participation in a minimum of two constituency or CDC meetings per year to facilitate the accomplishment of program objectives. Performance will be measured by the extent to which the program participates in or facilitates at least two meetings per year (annual, regional, etc.) to either gain information or to educate constituents in achieving the accomplishment of program goals and objectives.
d. Identify and select appropriate staff, organizational structure, communication processes to implement funded activities. Performance will be measured by the extent the program has put in place or maintained program infrastructure including staff and other resources to accomplish the goals and objectives of the program including organizational skills, human resources capability, and community involvement.
e. Establish specific, measurable, and realistic short-term (one year) and long-term (five year) program objectives consistent with the purpose of this program announcement for the accomplishment of program activities and to ensure sustainability after CDC funding. Performance will be measured by the extent to which measurable outcomes were achieved on time; whether project milestones were met and deliverables were of high quality; whether indicators of applicant capacity are adequate; and whether CDC involvement is appropriately represented by funded activities.
f. Evaluate achievement of each goal and objective through a well-designed evaluation plan. Performance will be measured by the extent to which the program has an evaluation plan with results used to develop program activities (i.e., a plan that includes a description of the stakeholder involvement, data collection and analysis methods, how the goals/objectives link to outcomes [the “logic” for the activity as well as that for choosing this element to be evaluated], potential effects of selected activities [process and outcome indicators], and plans for communication and utilization of the findings); and reports annually to CDC on evaluation results.
In a cooperative agreement, CDC staff is substantially involved in the program activities, above and beyond routine grant monitoring.
CDC activities for this program are as follows:
a. Collaborate with recipients in the development, implementation, evaluation, and dissemination of programs designed to improve knowledge, attitudes, prevention and screening behaviors, or survivorship in the priority populations.
b. Provide periodic updates about public knowledge, attitudes, and practices regarding prevention, early detection or survivorship of cancer, including up-to-date scientific information.
c. Collaborate with recipients to develop meeting agendas including identifying speakers/presenters.
d. Collaborate with recipients in the development of publications, manuals, modules, etc. that relate to the purpose of this program announcement.
e. Facilitate the exchange of program information, technical assistance, and the development of partnerships between recipients funded under this announcement and community organizations, health departments, and other partners.
Type of Award: Cooperative Agreement.
CDC’s involvement in this program is listed in the Activities Section above.
Award Mechanism: U50 - Special Cooperative Health Investigations and Assessments of Control and Prevention Methods
Fiscal Year Funds: 2008
Approximate Current Fiscal Year Funding: $ 2,200,000
Approximate Total Project Period Funding: $ 11,000,000. This amount is an estimate, and is subject to availability of funds.
Approximate Number of Awards: Approximately 6 to 8 awards.
Approximate Average Award: It is expected that the average award will be $250,000, will range from $100,000 to $350,000. Funding estimates may change.
Ceiling of Individual Award Range: None.
Anticipated Award Date: It is expected that the awards will begin on or about August 15, 2008 and will be made for a 12-month budget period within a project period of up to 5 years.
Throughout the project period, CDC’s commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the Federal government.
National organizations that serve as an umbrella organization for their constituents (regional or local chapters or memberships) provide a unique opportunity to address barriers to prevention and screening, improve quality of care, and improve the priority population’s access to cancer prevention, early detection, or survivorship programs.
Therefore, applications may be submitted by:
o
national, public and private nonprofit ando
faith-based organizationsSEQ CHAPTER \h \r 1that have the capacity and ability to conduct nationwide programs and activities related to cancer control and the promotion of health education, awareness, and information dissemination.
III.2. Cost Sharing or Matching
Cost sharing or matching funds are not required for this program.
III.3. Other
CDC will accept and review applications with budgets greater than the ceiling of the award range.
Special Requirements:
If the application is incomplete or non-responsive to the special requirements listed in this section, it will not be entered into the review process. The applicant will be notified the application did not meet submission requirements.
IV.1. Address to Request Application Package
To apply for this funding opportunity use the application forms package posted in Grants.gov.
Electronic Submission:
CDC strongly encourages the applicant to submit the application electronically by utilizing the forms and instructions posted for this announcement on www.Grants.gov, the official Federal agency wide E-grant Web site. Only applicants who apply on-line are permitted to forego paper copy submission of all application forms.
Registering your organization through www.Grants.gov is the first step in submitting applications online. Registration information is located in the “Get Registered” screen of www.Grants.gov. While application submission through www.Grants.gov is optional, we strongly encourage you to use this online tool.
Please visit www.Grants.gov at least 30 days prior to filing your application to familiarize yourself with the registration and submission processes. Under “Get Registered,” the one-time registration process will take three to five days to complete; however, as part of the Grants.gov registration process, registering your organization with the Central Contractor Registry (CCR) annually, could take several days to complete. We suggest submitting electronic applications several days prior to the closing date so if difficulties are encountered, you can submit a hard copy of the application prior to the deadline.
Paper Submission:
Application forms and instructions are available on the CDC Web site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/grants/app_and_forms.shtm
If access to the Internet is not available, or if there is difficulty accessing the forms on-line, contact the CDC Procurement and Grants Office Technical Information Management Section (PGO-TIMS) staff at 770-488-2700 and the application forms can be mailed.
IV.2. Content and Form of Submission
Letter of Intent (LOI):
Prospective applicants are asked to submit a letter of intent that includes the following information:
1. Selected cancer(s) and priority population(s)
2. Proposed constituency
3. Proposed outcomes
Your letter of intent will be used to enable CDC to determine the level of interest in this announcement and to assist in planning the objective review.
Application:
A Project Abstract must be submitted with the application forms. All electronic project abstracts must be uploaded in a PDF file format when submitting via Grants.gov. The abstract must be submitted in the following format, if submitting a paper application:
The Project Abstract must contain a summary of the proposed activity suitable for dissemination to the public. It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed. It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically literate lay reader. This Abstract must not include any proprietary/confidential information.
A Project Narrative must be submitted with the application forms. All electronic narratives must be uploaded in a PDF file format when submitting via Grants.gov. The narrative must be submitted in the following format, if submitting a paper application:
Use the information in the Program Requirements, Other Requirements, and Evaluation Criteria sections to develop the application content. Your application will be evaluated using Evaluation Criteria stated below.
The narrative should address activities to be conducted over the entire project period and should include the following items in the order listed:
Background and Need:
Describe the priority population as it relates to the purpose of this program announcement, the cancer disease burden of the selected cancer within the priority population, and barriers or gaps in cancer prevention, early detection and survivorship efforts.
Describe the applicant’s history and experience with program activities or any services provided to the priority population, and the rationale for use of previously conducted or newly developed innovative strategies to enhance the delivery of health messages, services, or programs regarding the prevention, early detection, or survival of cancer -- especially cancers of the breast, cervix, colon, prostate, ovary, or skin.
Project Management:
Describe the organization’s structure and function, size, national membership substructure, activities on a regional, state, or local level, and methods of routine communication with members.
Describe each current or proposed staff position for this program by job title, function, general duties, and activities with which that position will be involved. Include the level of effort and allocation of time for each project activity by staff position.
Collaborative Activities:
Describe past and proposed collaborative working partnerships with providers, community groups, or others who serve the priority population and have established linkages in the priority population.
Goals and Objectives:
Objectives: Identify specific, realistic, and time-phased, measurable, short-term (one year) and long-term (five year) objectives consistent with the intent of this program announcement.
Activities: Clearly identify the specific activities/strategies that will be undertaken to achieve each of the proposed short-term objectives during the budget period.
Milestone Chart: Submit a milestone-to-completion chart consistent with the time frame.
Program Evaluation Plan:
Identify methods for measuring progress toward attaining program goals and objectives and monitoring activities consistent with this program announcement. The evaluation plan should include quantitative assessment mechanisms; the outcome expected; the minimum information to be collected and the system(s) for reporting the information.
Budget and Justification:
Provide a detailed line item budget and narrative justification of all operating expenses consistent with the proposed objectives and planned activities. Be precise about program purpose of each budget item and itemize calculations when appropriate.
Participation in CDC sponsored training, workshops, or program meetings is essential to the effective implementation of cancer prevention, early detection, or survivorship programs. Over the five-year project period, travel funds should be budgeted for the following meetings: two persons to Atlanta, Georgia to attend the National Cancer Prevention and Control Conference (three days); three to five persons to Atlanta, Georgia to attend at a minimum in Year 01 an orientation, and to report program implementation progress (reverse site visit) and for consultation and technical assistance (two days, one trip per year); up to two additional two-person trips to Atlanta, or other destinations to attend or assist with national workgroups, task forces, or committees (one to three days).
The budget and budget justification will be included as a separate attachment, not to be counted in the narrative page limit. Additional information may be included in the application appendices. Applicants should also submit appendices (including curriculum vitae, job descriptions, organizational charts, and any other supporting documentation), which should not exceed an additional 20 pages.
Additional information submitted via Grants.gov should be uploaded in a PDF file format, and should be named:
The agency or organization is required to have a Dun and Bradstreet Data Universal Numbering System (DUNS) number to apply for a grant or cooperative agreement from the Federal government. The DUNS number is a nine-digit identification number, which uniquely identifies business entities. Obtaining a DUNS number is easy and there is no charge. To obtain a DUNS number, access the Dun and Bradstreet website or call 1-866-705-5711.
Additional requirements that may request submission of additional documentation with the application are listed in section “VI.2. Administrative and National Policy Requirements.”
Application Deadline Date: June 23, 2008
Explanation of Deadlines: LOIs and applications must be received in the CDC Procurement and Grants Office by 5:00 p.m. Eastern Time on the deadline date.
Applications may be submitted electronically at www.Grants.gov. Applications completed on-line through Grants.gov are considered formally submitted when the applicant organization’s Authorizing Organization Representative (AOR) electronically submits the application to www.Grants.gov. Electronic applications will be considered as having met the deadline if the application has been successfully submitted electronically by the applicant organization’s AOR to Grants.gov on or before the deadline date and time.
When submission of the application is done electronically through Grants.gov (http://www.grants.gov), the application will be electronically time/date stamped and a tracking number will be assigned, which will serve as receipt of submission. The AOR will receive an e-mail notice of receipt when HHS/CDC receives the application.
If submittal of the application is by the United States Postal Service or commercial delivery service, the applicant must ensure that the carrier will be able to guarantee delivery by the closing date and time. The applicant will be given the opportunity to submit documentation of the carrier’s guarantee, if HHS/CDC receives the submission after the closing date due to: (1) carrier error, when the carrier accepted the package with a guarantee for delivery by the closing date and time; or (2) significant weather delays or natural disasters. If the documentation verifies a carrier problem, HHS/CDC will consider the submission as having been received by the deadline.
If a hard copy application is submitted, HHS/CDC will not notify the applicant upon receipt of the submission. If questions arise on the receipt of the application, the applicant should first contact the carrier. If the applicant still has questions, contact the PGOTIMS staff at (770) 488-2700. The applicant should wait two to three days after the submission deadline before calling. This will allow time for submissions to be processed and logged.
This announcement is the definitive guide on LOI and application content, submission address, and deadline. It supersedes information provided in the application instructions. If the application submission does not meet the deadline above, it will not be eligible for review. The application face page will be returned by HHS/CDC with a written explanation of the reason for non-acceptance. The applicant will be notified the application did not meet the submission requirements.
IV.4. Intergovernmental Review of Applications
Executive Order 12372 does not apply to this program.
IV.5. Funding Restrictions
Restrictions, which must be taken into account while writing the budget, are as follows:
If requesting indirect costs in the budget, a copy of the indirect cost rate agreement is required. If the indirect cost rate is a provisional rate, the agreement should be less than 12 months of age. The indirect cost rate agreement should be uploaded as a PDF file with “Other Attachment Forms” when submitting via Grants.gov.
The recommended guidance for completing a detailed justified budget can be found on the CDC Web site, at the following Internet address:
http://www.cdc.gov/od/pgo/funding/budgetguide.htm.
IV.6. Other Submission Requirements
LOI Submission Address: Submit the LOI by express mail, delivery service, fax, or E-mail to:
Phyllis Rochester, PhD., Project Officer
Division of Cancer Prevention and
Control
Centers for Disease Control and Prevention
4770 Buford Highway, MS K-57
Atlanta, GA 30341
Telephone: 770 488-3096
E-mail: Pfr5@cdc.gov
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows CDC Program staff to estimate the potential review workload and plan the review.
The letter of intent is to be sent by the date listed in Section IV.3.A.
LOI Submission Address: Submit the LOI by express mail or delivery service to:
Technical Information Management – FOA DP08-815
Department of Health and Human Services
CDC Procurement and Grants Office
2920 Brandywine Rd, MS E-14
Atlanta, GA 30341
Application Submission Address:
Electronic Submission:
HHS/CDC strongly encourages applicants to submit applications electronically at www.Grants.gov. The application package can be downloaded from www.Grants.gov. Applicants are able to complete it off-line, and then upload and submit the application via the Grants.gov Web site. E-mail submissions will not be accepted. If the applicant has technical difficulties in Grants.gov, customer service can be reached by E-mail at support@grants.gov or by phone at 1-800-518-4726 (1-800-518-GRANTS). The Customer Support Center is open from 7:00a.m. to 9:00p.m. Eastern Time, Monday through Friday.
HHS/CDC recommends that submittal of the application to Grants.gov should be prior to the closing date to resolve any unanticipated difficulties prior to the deadline. Applicants may also submit a back-up paper submission of the application. Any such paper submission must be received in accordance with the requirements for timely submission detailed in Section IV.3. of the grant announcement. The paper submission must be clearly marked: “BACK-UP FOR ELECTRONIC SUBMISSION.” The paper submission must conform to all requirements for non-electronic submissions. If both electronic and back-up paper submissions are received by the deadline, the electronic version will be considered the official submission.
The applicant must submit all application attachments using a PDF file format when submitting via Grants.gov. Directions for creating PDF files can be found on the Grants.gov Web site. Use of file formats other than PDF may result in the file being unreadable by staff.
AND
Paper Submission:
Applicants should submit the original and two hard copies of the application by mail or express delivery service to:
2920 Brandywine Road, MS E-14
Atlanta, GA 30341
V.1. Criteria
Applicants are required to provide measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the cooperative agreement]. Measures of effectiveness must relate to the performance goals stated in the “Purpose” section of this announcement. Measures must be objective and quantitative and must measure the intended outcome. The measures of effectiveness must be submitted with the application and will be an element of evaluation.
The application will be evaluated against the following criteria:
1. Criteria:
A. Project Narrative
1) Background and Need (15 points)
a) To what extent does the applicant use credible data sources and evidence to describe relevant disease burden and problems? (5 points)
b) To what extent does the applicant use guidelines such as The Community Guide? (5 points)
c) To what extent is a compelling justification of need and appropriateness for proposed activities provided? (5)
B. Capacity (25 points)
1) To what extent does the applicant describe that existing organizational structure supports the activities to implement comprehensive cancer control?
2) To what extent does the applicant describe experience appropriate to the level (local, community, regional, or international) of the activities?
C. Project management and staffing (30 points)
1) Does the applicant have the qualified scientific and programmatic staff designated for an appropriate amount of time to complete the work? (15 points)
2) Does the applicant provide clear job descriptions? (5 points)
3) To what extent is the fiscal management and oversight for the proposed activities clear and adequate, with the business office staff identified? (required, not scored)
4) Does the applicant describe a plan to facilitate communication among the grantee and CDC project leads and managers? (5 points)
5) Does the applicant describe an appropriate plan to facilitate integration and communication between the grantee and other collaborative partners? (5 points)
D. Workplan (30 points)
1) To what extend does the applicant propose goals that are specific and feasible for the fine-year project period and consistent with the purpose and requirements of the announcement? (5 points)
2) To what extent does the applicant propose objectives for the first annual budget period that are specific, measurable, achievable, realistic, and time-phased (SMART) and directly related to the goals, purpose, performance measures, program requirements, and data provided in the Background and Need section? (10 points)
3) To what extent does the applicant describe activities that are likely to achieve the objectives identified, provide a realistic timeline, and identify the person(s)/organization responsible for each activity? (10 points)
4) To what extent does applicant provide measures of effectiveness for activities in the work plan? (5 points)
E. Project Abstract (required; not scored; one (1) page maximum)
F. Budget Narrative (required; not scored; no page limitation)
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff, and for responsiveness jointly by NCCDPHP and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified the application did not meet submission requirements.
An objective review panel will evaluate complete and responsive applications according to criteria listed in the “V.1.Criteria.”
Applications will be funded in order by score and rank determined by the review panel.
CDC will provide justification for any decision to fund out of rank order.
VI.1. Award Notices
Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and emailed to the program director and a hard copy mailed to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of the application review by mail.
VI.2. Administrative and National Policy Requirements
Successful applicants must comply with the administrative requirements outlined in 45 CFR Part 74 and Part 92, as appropriate. The following additional requirements apply to this project
Additional information on the requirements can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/Addtl_Reqmnts.htm.
CDC Assurances and Certifications can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/grants/foamain.shtm
For more information on the Code of Federal Regulations, see the National Archives and Records Administration at the following Internet address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html
VI.3. Reporting Requirements
The applicant must provide CDC with an annual interim progress report via www.grants.gov:
1.
The interim progress report is due March 31 of each year. The progress report will serve as the non-competing continuation application, and must contain the following elements:a.
Standard Form (“SF”) 424S Form.b.
SF-424A Budget Information-Non-Construction Programs.c.
Budget Narrative.d.
Indirect Cost Rate Agreement.e.
Project Narrative.Additionally, the applicant must provide CDC with an original, plus two hard copies of the following reports:
2.
Financial status report and annual progress report, no more than 90 days after the end of the budget period.These reports must be submitted to the attention of the Grants Management Specialist listed in the “VII. Agency Contacts” section of this announcement.
CDC encourages inquiries concerning this announcement.
For general questions, contact:
CDC Procurement and Grants Office
2920 Brandywine Road, MS E-14
Atlanta, GA 30341
Telephone: 770-488-2700
For program technical assistance, contact:
Phyllis Rochester, PhD., Project Officer
Division of Cancer Prevention and
Control
Centers for Disease Control and Prevention
4770 Buford Highway, MS K-57
Atlanta, GA 30341
Telephone: 770 488-3096
E-mail: Pfr5@cdc.gov
For financial, grants management, or budget assistance, contact:
Stephanie Lankford, Grants Management Specialist
CDC Procurement and Grants Office
2920 Brandywine Road, MS E09
Telephone: 770-488-2936
E-mail: slankford@cdc.gov
CDC Telecommunications for the hearing impaired or disabled is available at: TTY 770-488-2783.
VIII. Other Information
Other CDC funding opportunity announcements can be found on the CDC Web site, Internet address: http://www.cdc.gov/od/pgo/funding/FOAs.htm.
Applicants may access the application process and other awarding documents using the Electronic Research Administration System (eRA Commons). A one-time registration is required for interested institutions/organizations at http://era.nih.gov/ElectronicReceipt/preparing.htm
Program Directors/Principal Investigators (PD/PIs) should work with their institutions/organizations to make sure they are registered in the eRA Commons.
1.
Organizational/Institutional Registration in the eRA Commons2. Project Director/Principal Investigator (PD/PI) Registration in the eRA Commons: Refer to the NIH eRA Commons System (COM) Users Guide.
Note that if a PD/PI is also an HHS peer-reviewer with an Individual DUNS and CCR registration, that particular DUNS number and CCR registration are for the individual reviewer only. These are different than any DUNS number and CCR registration used by an applicant organization. Individual DUNS and CCR registration should be used only for the purposes of personal reimbursement and should not be used on any grant applications submitted to the Federal Government.
Several of the steps of the registration process could take four weeks or more. Therefore, applicants should check with their business official to determine whether their organization/institution is already registered in the eRA Commons. HHS/CDC strongly encourages applicants to register to utilize these helpful on-line tools when applying for funding opportunities.
CDC Home Page: http://www.cdc.gov
CDC Funding Web Page: http://www.cdc.gov/od/pgo/funding/FOAs.htm
CDC Forms Web Page:
http://www.cdc.gov/od/pgo/funding/grants/app_and_forms.shtm